Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 02, 2007. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) in accordance with Disclosure Rule 3.1.4R(1)(a).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notification regarding insider trading and does not contain financial performance data.
Material Changes
The only material change reported is a transaction by a senior executive:
- Mr. A. Witty sold 6,000 Ordinary Shares on March 30, 2007.
- The transaction price was GBP 13.93 per share.
- The company was advised of this transaction on April 02, 2007.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the total shareholding of Mr. A. Witty following the sale of 6,000 shares.
- Confirm the market price of GlaxoSmithKline plc shares on March 30, 2007, to assess the transaction price relative to market value.
- Review subsequent filings to determine if other PDMRs have executed similar transactions.